BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33469310)

  • 1. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
    Ou W; Zhou C; Zhu X; Lin L; Xu Q
    Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
    Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
    Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of lymphocyte to C-reactive protein ratio in predicting survival and postoperative complication for esophago-gastric junction cancer.
    Tsujiura M; Yamamoto A; Imaoka H; Shimura T; Kitajima T; Morimoto Y; Kawamura M; Yasuda H; Okita Y; Yokoe T; Okugawa Y; Ohi M; Toiyama Y
    Surg Oncol; 2022 Sep; 44():101842. PubMed ID: 36081281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer.
    Zhou Y; Cheng F; Zhang Z; Xiang J; Xue T; Ye Q; Yan B
    Clin Med Insights Oncol; 2022; 16():11795549221126249. PubMed ID: 36186673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Lymphocyte-C-Reactive Protein Ratio in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study.
    Zhang H; Wang Y; Ni J; Shi H; Zhang T; Zhang Y; Guo J; Wang K; Mao W; Peng B
    Front Oncol; 2021; 11():760389. PubMed ID: 34778081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
    Wang L; Zhang YL; Jiang C; Duan FF; Yuan ZY; Huang JJ; Bi XW
    J Inflamm Res; 2022; 15():3957-3974. PubMed ID: 35860229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma.
    Hu H; Deng X; Song Q; Lv H; Chen W; Xing X; Zhu J; Tan Z; Cheng X; Wang B; Shao Z; Zhang Y
    Onco Targets Ther; 2020; 13():12673-12681. PubMed ID: 33328739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study.
    Cheng CB; Zhang QX; Zhuang LP; Sun JW
    Jpn J Clin Oncol; 2020 Sep; 50(10):1141-1149. PubMed ID: 32564084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer.
    Zhou J; Wei W; Hou H; Ning S; Li J; Huang B; Liu K; Zhang L
    Front Cell Dev Biol; 2021; 9():637650. PubMed ID: 34765598
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer.
    Yao WY; Wu XS; Liu SL; Wu ZY; Dong P; Gong W
    Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):267-272. PubMed ID: 34507896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer.
    Iseda N; Iguchi T; Hirose K; Itoh S; Honboh T; Sadanaga N; Matsuura H
    Am Surg; 2023 Nov; 89(11):4452-4458. PubMed ID: 35920820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
    Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
    Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the Lymphocyte-to-C-Reactive Protein Ratio and Survival Outcomes in Cancer Patients with GLIM-Defined Malnutrition: A Multicenter Study.
    Zhang KP; Zhang X; Zhang Q; Ruan GT; Song MM; Xie HL; Zhang HY; Li XR; Yang M; Liu YY; Li QQ; Ge YZ; Liu XY; Lin SQ; Li W; Xu HX; Deng L; Shi HP
    J Nutr Health Aging; 2022; 26(9):847-855. PubMed ID: 36156676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
    Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
    Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma.
    Fang KH; Lai CH; Hsu CM; Huang E; Tsai MS; Chang GH; Lee YC; Tsai YT
    PeerJ; 2020; 8():e9361. PubMed ID: 32587804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
    Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
    BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer.
    Huang Z; Cai P; Zhao Y; Niu D; Xu F; Lai Y; Pang J; Qi J; Wu J
    J Surg Oncol; 2022 Jun; 125(8):1238-1250. PubMed ID: 35174885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.